Ranked #350 of 8,699 institutional investors
a16z Capital Management, L.L.C.
Menlo Park, CA
$17.16B
US stock portfolio at live prices · today −$1.18B (−6.42%)
Live prices, last trade 12:24 PM ET
- Value at quarter end (Q3 2026)
- $19.89B
- Change from Q2 2026
- +$5.68B (+39.95%)
- Positions
- 22 · 6 new, 1 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$26.3M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesSPCX 91.3%NAVN 4.08%BRVE 1.20%RVMD 0.74%XYZ 0.42%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| SPCX Space Exploration Technologies Corp. | 121,777,808 | $15.67B | 91.3% | Added +63% |
| NAVN Navan, Inc. | 28,218,676 | $701M | 4.08% | Unchanged |
| BRVE Braveheart Bio, Inc. | 10,232,420 | $207M | 1.20% | New |
| RVMD Revolution Medicines, Inc. | 782,934 | $126M | 0.74% | Reduced −15% |
| XYZ Block, Inc. | 1,016,697 | $72.7M | 0.42% | Unchanged |
| LIME Neutron Holdings, Inc. | 2,849,097 | $58.8M | 0.34% | New |
| MAZE Maze Therapeutics, Inc. | 1,702,225 | $54.3M | 0.32% | Unchanged |
| FRNM Freenome, Inc. | 5,571,599 | $53.0M | 0.31% | New |
| FIG Figma, Inc. | 2,565,731 | $42.1M | 0.25% | Reduced −57% |
| SCTX Scribe Therapeutics Inc. | 3,082,725 | $37.9M | 0.22% | New |
| STDN Standard Nuclear, Inc. | 2,924,890 | $24.6M | 0.14% | New |
| ERAS Erasca, Inc. | 1,431,250 | $20.1M | 0.12% | Reduced −50% |
| BIOA BioAge Labs, Inc. | 3,233,170 | $14.4M | <0.1% | Unchanged |
| RBLX Roblox Corporation | 274,570 | $12.9M | <0.1% | Unchanged |
| META Meta Platforms, Inc. | 20,951 | $12.0M | <0.1% | Reduced −90% |
| CAMP Camp4 Therapeutics Corp | 2,125,339 | $8.5M | <0.1% | Unchanged |
| AKTS Aktis Oncology, Inc. | 415,000 | $6.7M | <0.1% | Unchanged |
| NAUT Nautilus Biotechnology, Inc. | 2,656,655 | $5.4M | <0.1% | Reduced −71% |
| BTGO Bitgo Holdings Inc-Cl A | 666,356 | $2.3M | <0.1% | Unchanged |
| BLSM BlossomHill Therapeutics, Inc. | 125,000 | $1.8M | <0.1% | New |
| KLRA Kailera Therapeutics, Inc. | 140,000 | $1.6M | <0.1% | Unchanged |
| DNA Ginkgo Bioworks Holdings, Inc. | 108,568 | $836K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| OMDA Omada Health, Inc. | 1,153,639 | $13.9M |